COVID-19 and Fungal Infection
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In November 2019, the coronavirus disease-2019 (COVID-19) outbreak was first reported. The infection of COVID- 19 has rapidly spread worldwide. Some have unapparent or mild symptoms, but some patients have fatal forms including respiratory or multiple organ failure. In March 2020, the World Health Organization announced COVID-19 as pandemic disease. The COVID-19 pandemic is a sudden, difficult-to-control, and severe disease that can also appear to patients in dermatology. However, understanding disease and experience with it is still insufficient. Therefore, we would like to review patients with fungal infections in the COVID-19 pandemic era.
Abstract
In November 2019, the coronavirus disease-2019 (COVID-19) outbreak was first reported. The infection of COVID- 19 has rapidly spread worldwide. Some have unapparent or mild symptoms, but some patients have fatal forms including respiratory or multiple organ failure. In March 2020, the World Health Organization announced COVID-19 as pandemic disease. The COVID-19 pandemic is a sudden, difficult-to-control, and severe disease that can also appear to patients in dermatology. However, understanding disease and experience with it is still insufficient. Therefore, we would like to review patients with fungal infections in the COVID-19 pandemic era.
참고문헌 (26)
- "Coronavirus disease 2019(COVID-19) Situation Report – 51" (2020)[URL]
- Wu Z, "Characteristics of and important lessons from the Coronavirus disease 2019(COVID-19)outbreak in China : Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention", JAMA, 323, pp.1239~1242 (2020)
- Zhou P, "A pneumonia outbreak associated with a new coronavirus of probable bat origin", Nature, 579, pp.270~273 (2020)
- Walls AC, "Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein", Cell, 181, pp.281~292 (2020)
- Yan R, "Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2", Science, 367, pp.1444~1448 (2020)
- "Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations"[URL]
- Gandhi RT, "Mild or moderate Covid-19", N Engl J Med (2020)
- Berlin DA, "Severe Covid-19", N Engl J Med (2020)
- Marzano AV, "Cutaneous manifestations in patients with COVID-19 : a preliminary review of an emerging issue", Br J Dermatol, 183, pp.431~442 (2020)
- Jia JL, "Cutaneous manifestations of COVID-19 : A preliminary review", J Am Acad Dermatol, 83, pp.687~690 (2020)
- Henry D, "Urticarial eruption in COVID-19 infection", J Eur Acad Dermatol Venereol, 34, pp.e244~ (2020)
- Fernandez-Nieto D, "Comment on: Cutaneous manifestations in COVID-19:a first perspective. Safety concerns of clinical images and skin biopsies", J Eur Acad Dermatol Venereol, 34, pp.e252~ (2020)
- Quintana-Castanedo L, "Urticarial exanthem as early diagnostic clue for COVID-19 infection", JAAD Case Rep, 6, pp.498~499 (2020)
- van Damme C, "Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection", J Eur Acad Dermatol Venereol, 34, pp.e300~ (2020)
- Recalcati S, "Cutaneous manifestations in COVID-19 : a first perspective", J Eur Acad Dermatol Venereol, 34, pp.e212~ (2020)
- Zhu X, "Coinfection with respiratory pathogens among COVID-2019cases", Virus Res, 285, pp.198005~ (2020)
- Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:a descriptive study", Lancet, 395, pp.507~513 (2020)
- Yang X, "Clinical course and outcomes of critically ill patients with SARSCoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study", Lancet Respir Med, 8, pp.475~481 (2020)
- Zhang G, "Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China", J Clin Virol, 127, pp.104364~ (2020)
- Verweij PE, "Diagnosing COVID-19-associated pulmonary aspergillosis", Lancet Microbe, 1, pp.e53~ (2020)
- Meijer EFJ, "Azole-resistant COVID-19-associated pulmonary aspergillosis in an immunocompetent host: A case report", J Fungi(Basel), 6, pp.79~ (2020)
- van Arkel ALE, "COVID-19-associated pulmonary aspergillosis", Am J Respir Crit Care Med, 202, pp.132~135 (2020)
- Alanio A, "Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19", Lancet Respir Med, 8, pp.e48~ (2020)
- Koehler P, "COVID-19 associated pulmonary aspergillosis", Mycoses, 63, pp.528~534 (2020)
- Rawson TM, "Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing", Clin Infect Dis, pp.ciaa530~ (2020)
- Hughes S, "Bacterial and fungal coinfection among hospitalized patients with COVID-19 : a retrospective cohort study in a UK secondary-care setting", Clin Microbiol Infect, 26, pp.1395~1399 (2020)